Skip to content
Companies

Pacific Diabetes Technologies

Combined glucose sensor and insulin delivery in one device

Raised to date

$5.4M

of $8.5M offered across 3 Form D filings

Still open
$3.1M
Investors
5
Last filed
Nov 17, 2025

About

Pacific Diabetes Technologies, Inc. (PDT) is a pioneering company focused on developing advanced diabetes management devices aimed at streamlining treatment for individuals with insulin-dependent diabetes. Their innovative approach integrates multiple functions into a single device to enhance user experience and improve health outcomes.

PDT distinguishes itself by offering a single-port device that amalgamates glucose monitoring and insulin delivery, significantly reducing the complexity of diabetes management.

Funding

Mar 20252026
Now

$5M round, first sold Mar 2025: $2.1M sold, $2.9M still open

  • DebtFiled Nov 17, 2025Form D/A
    $3.4M/ $3.5M
  • DebtFiled Oct 20, 2025Form D
    $2.9M/ $3M
  • EquityFiled Mar 14, 2025Form D
    $2.1M/ $5M

Product

SynerG™ Device

Diabetes Management Device

The SynerG™ device is a revolutionary combination of continuous glucose monitoring and insulin delivery systems, designed to be worn as a single unit. This innovative device eliminates the necessity for separate devices, making diabetes management more efficient and less intrusive.

  • Combines CGM and insulin delivery functions
  • Single-port design for ease of use
  • Minimizes the need for multiple insertion sites

Built for

Individuals with insulin-dependent diabetes

People on file